StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
NTH.MC$2.56+1.19%
Fair $2.56+0.0%

NTH.MC

Naturhouse Health, S.A.

Consumer Defensive / Packaged FoodsMCE

$2.56

+0.03 (+1.19%)

Fairly Valued+0.0%Fair Value $2.56Fund rank 36/100 · Data gapFallback financials|
SA 50/C
F-Score: 6/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $11.7M · quality 75.7/100

Data gap 36/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 68/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

50/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 3 consecutive years
Thesis & Journal · NTH.MCLocal privado en este navegador · Naturhouse Health, S.A.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$153M

P/E

15.1x

↓

EV/EBITDA

9.6x

↑

ROE

56.9%

↑

Gross Margin

72.0%

↑

Debt/Equity

0.14

↓
52-Week Range$3
$2$3

TradingView lightweight chart

NTH.MC price, volumen y niveles de valoración

Último $2.550Periodo -48.9%
Fair value: $2.560

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-3.1%

FCF CAGR

+23.9%

FCF margin

24.5%

FCF / Net income

1.16x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $47.6M · net income $10.1M · FCF $11.7M

2022-FY → 2025-FY

Gross margin

72.0%+0.4% pts

Operating margin

27.8%+3.3% pts

Net margin

21.2%+2.8% pts

FCF margin

24.5%+12.8% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$47.6M$47.6M$49.4M$50.4M$52.4M
Net Income$10.1M$10.1M$9.9M$11.3M$9.6M
EBITDA$14.9M$14.9M$15.6M$18.3M$15.6M
EPS——0.160.190.16
Gross Margin72.0%72.0%71.8%72.8%71.5%
Operating Margin27.8%27.8%26.6%32.3%24.5%
Net Margin21.2%21.2%20.0%22.4%18.4%
Balance Sheet
Debt/Equity0.140.140.100.100.12
Current Ratio1.651.65———
Cash Flow
Free Cash Flow$11.7M$11.7M$11.2M$20.4M$6.1M
Returns
ROE56.9%56.9%31.1%36.9%34.6%
Valuation
P/E15.0615.0610.669.0810.34
EV/EBITDA9.559.555.414.495.79
P/B8.658.653.233.383.57
Growth & Yield
Revenue Growth-3.6%-3.6%-1.9%-3.8%—
EPS Growth——-15.8%18.8%—
Dividend Yield13.7%13.7%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +58.2%

Total return

+58.2%

Start / end P/E

n/dx → n/dx

EPS bridge

0.16 → n/d

Residual

+44.5%

EPS growthn/d
Multiple reratingn/d
Dividend+13.7%
Residual / FX / buybacks / cross-term+44.5%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.